Early heart disease trial for women and men with mild plaque buildup
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women must be between 40 and 60 years old, men between 30 and 50 years old
- You must have a small amount of calcium or soft plaque in your heart arteries (detected by a CT scan)
- You must own and use a smartphone
- You cannot have had a heart attack, stroke, or other heart disease diagnosis
- You cannot currently be taking cholesterol-lowering medications or colchicine
- If you are a woman who could get pregnant, you must agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether starting strong cholesterol-lowering treatment early can reduce or reverse plaque in the arteries. It may help protect the heart over time, especially for people with inherited high cholesterol.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
This trial studies how short-term statin therapy changes plaque buildup in heart arteries. It uses CT scans to see if statins can make plaques more stable and reduce heart risks.
This trial compares a combo of statin and ezetimibe without aspirin against statin alone with aspirin in people with high coronary calcium but no blocked arteries. It aims to find which approach is safer and more effective without causing bleeding risk.
Hear when a new Coronary Artery Disease Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.